Abstract

Fertility preservation is a novel clinical discipline aiming to protect the fertility potential of young adults and children at risk of infertility. The field is evolving quickly, enriched by advances in assisted reproductive technologies and cryopreservation methods, in addition to surgical developments. The best-characterized target group for fertility preservation is the patient population diagnosed with cancer at a young age since the bulk of the data indicates that the gonadotoxicity inherent to most cancer treatments induces iatrogenic infertility. Since improvements in cancer therapy have resulted in increasing numbers of long-term survivors, survivorship issues and the negative impact of infertility on the quality of life have come to the front line. These facts are reflected in an increasing number of scientific publications referring to clinical medicine and research in the field of fertility preservation. Cryopreservation of gametes, embryos, and gonadal tissue has achieved quality standards for clinical use, with the retrieval of gonadal tissue for cryopreservation being currently the only method feasible in prepubertal children. Additionally, the indications for fertility preservation beyond cancer are also increasing since a number of benign diseases and chronic conditions either require gonadotoxic treatments or are associated with premature follicle depletion. There are many remaining challenges, and current research encompasses clinical health care and caring sciences, ethics, societal, epidemiological, experimental studies, etc.

Highlights

  • Introduction published maps and institutional affilThe preservation of fertility potential is an important issue for young people at risk of becoming infertile due to clinical conditions, diseases, or treatments

  • After a successful procedure resulting in a number of mature oocytes cryopreserved, the chances for fertility treatment resulting in children in the future is good [16]

  • Long-term efficacy of fertility preservation in populations of young women with breast cancer can be measured as utilization rates of cryopreserved specimens after completed treatment or as subsequent pregnancy and live-birth rates

Read more

Summary

Fertility Preservation in Girls and Teenagers Presenting with Turner Syndrome

One of the most characteristic symptoms of Turner syndrome, and the most distressing to the women with the syndrome, is infertility due to ovarian failure and the typical streak ovaries. There are, girls with Turner syndrome who present with signs of ovarian function in childhood and adolescence but have a risk of development of premature ovarian failure. The recommended way to find the girls that have functioning ovaries and provide advice on fertility preservation at an early age is by taking repeated anti-Müllerian hormone (AMH) tests during childhood and adolescence [23,24]. After a successful procedure resulting in a number of mature oocytes cryopreserved, the chances for fertility treatment resulting in children in the future is good [16]. In all discussions of fertility preservation in women with Turner syndrome, other medical problems that may limit the chances to fulfill a pregnancy using own-preserved or donated oocytes need to be considered [22,26,29].

Fertility Preservation in Women with Breast Cancer
Fertility Preservation in Women with Gynecological Cancer
Epidemiological Research of Long-Term Outcomes of Fertility Preservation
Findings
Pharmaceutical Research and Stem Cell Strategies in Fertility Preservation
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call